Search clinical trials for: AD-2011 10/20 mg
Total 2174 results
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedMItochondrial MyopathiesUnited States, Denmark
-
Livzon Pharmaceutical Group Inc.Completed
-
Alaunos TherapeuticsCompletedMetastatic Breast CancerUnited States
-
TakedaCompletedDiabetes MellitusJapan
-
Ambrilia Biopharma, Inc.TerminatedAcromegalyUnited States, Belarus, Hungary, Serbia, Ukraine, Romania
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
Alaunos TherapeuticsCompletedGlioblastoma Multiforme | Anaplastic OligoastrocytomaUnited States
-
Organon and CoCompleted
-
EMD SeronoTerminatedRelapsing Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, Hungary, Poland, Ukraine, Finland, United Kingdom, Greece, Serbia
-
Healthgen Biotechnology Corp.RecruitingEmphysema Secondary to Congenital AATDUnited States
-
Vidac PharmaPharPoint Research, Inc.; Therapeutics, Inc.; Medistat Ltd., IsraelCompleted
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Colombia, Spain, Germany, Sweden, Italy
-
EyePoint Pharmaceuticals, Inc.Medical Technology Enterprise Consortium (MTEC)TerminatedCOVID-19 | Acute Respiratory Distress Syndrome (ARDS)United States
-
H. Lundbeck A/SCompleted
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)Denmark, United Kingdom, Czechia, France, Greece, Hungary, Slovakia, Sweden
-
Samsung Medical CenterHanmi Pharmaceutical co., ltd.Active, not recruitingCoronary Artery DiseaseKorea, Republic of
-
University Hospital FreiburgEssex Pharma GmbHCompletedHypercholesterolemia | Diabetes Mellitus Type 2Germany
-
Janssen Research & Development, LLCCompleted
-
Organon and CoCompleted
-
Vanda PharmaceuticalsCompletedNon-24-Hour-Sleep-Wake Disorder
-
Lpath, Inc.CompletedHealthy SubjectsUnited States
-
Kang Stem Biotech Co., Ltd.RecruitingSafety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) (smart(FURIN))Dermatitis, AtopicKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Reata, a wholly owned subsidiary of BiogenAbbVie; Friedreich's Ataxia Research AllianceActive, not recruitingFriedreich AtaxiaUnited States, Australia, Austria, Italy, United Kingdom
-
PfizerTerminated
-
Wyeth is now a wholly owned subsidiary of PfizerTerminated
-
Peking Union Medical College HospitalNot yet recruiting
-
PfizerCompleted
-
Tonix Pharmaceuticals, Inc.Completed
-
Janssen Research & Development, LLCCompleted
-
Virginia Commonwealth UniversityTerminated
-
BayerCompletedPharmacokineticsGermany
-
Rennes University HospitalInstitut National de la Recherche AgronomiqueCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Nanfang Hospital of Southern Medical UniversityUnknown
-
Eisai Co., Ltd.Completed
-
Bristol-Myers SquibbCompleted
-
PfizerCompleted
-
Rhodes Pharmaceuticals, L.P.CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Alvogen KoreaUnknown
-
Teva Pharmaceuticals USACompleted
-
Flame BiosciencesWithdrawnGastric Cancer | Solid Tumor | Pancreas Cancer
-
Lundbeck FoundationCompletedPostoperative Pain | Analgesic EfficacyDenmark
-
Tourmaline Bio, Inc.RecruitingThyroid Eye DiseaseUnited States, Jordan
-
Ayesha De CostaBoston Children's Hospital; Muhimbili University of Health and Allied Sciences and other collaboratorsCompleted
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiasKorea, Republic of
-
Oncology Institute of Southern SwitzerlandWithdrawn
-
Organon and CoCompleted
-
Taipei Veterans General Hospital, TaiwanCompleted
-
PfizerCompletedHealthy | Diabetes Mellitus, Type 2 | Renal ImpairmentUnited States